| 2012 | | Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy | 김현아, 서창희 |
| 2019 | | Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향, 정주양 |
| 2003 | | Differences in MMP-2, MMP-9, TIMP-1, and eosinophil inflammatory markers of nasal polyp homogenates between aspirin intolerant and tolerant asthma | 김선신, 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2020 | | DISEASE ACTIVITY IS IMPORTANT RISK FACTORS FOR MATERNAL AND FETAL OUTCOMES DURING PREGNANCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | 김지원, 김현아, 서창희, 정주양 |
| 2018 | | Effect of fenofibrate on uric acid level in patients with gout | 김현아, 서창희, 윤덕용, 정주양, 최영 |
| 2021 | | Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis | 김현아 |
| 2021 | | Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: Real-world data from the KOBIO registry | 김현아 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2022 | | Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-α inhibitors and utilization of machine-learning algorithms | 김현아, 정주양 |
| 2018 | | Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach | 김현아 |
| 2019 | | Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study | 김현아 |
| 2023 | | Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | 서창희 |
| 2019 | | Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study | 서창희 |
| 2014 | | Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study. | 서창희 |
| 2020 | | Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies | 서창희 |
| 2017 | | Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis | 서창희 |
| 2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
| 2022 | | Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry | 김현아 |
| 2016 | | Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases | 김현아 |
| 2017 | | Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial | 서창희 |
| 2017 | | Elevated circulating levels of the interferon-gamma-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2022 | | Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2016 | | Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash | 김현아, 서창희, 손성향, 정주양 |
| 2004 | | Elevated level of serum tryptase in a patient with exercise-inuced anaphylaxis | 남동호, 박해심, 서유진, 서창희, 예영민, 임선교, 최정희 |
| 2015 | | Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study. | 김현아, 서창희, 정주양 |
| 2014 | | Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. | 서창희 |
| 2021 | | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83 | 김현아, 서창희, 손성향, 유혜명, 정주양 |
| 2019 | | Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study | 부선주, 서창희, 정주양 |
| 2013 | | Exacerbation of Lupus Nephritis in Pregnant Women with Remission of Lupus Nephritis | 강은정, 김현아, 서창희, 임현이, 전자영, 정주양 |
| 2022 | | Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study | 김지원, 부선주, 서창희 |
| 2018 | | Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months | 서창희 |
| 2021 | | Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2015 | | FcγRIIB Gene Polymorphisms Are Associated with Disease Risk and Clinical Manifestations of Systemic Lupus Erythematosus in Koreans. | 김현아, 서창희, 정주양 |
| 2003 | | Fibromyalgia | 서창희 |
| 2022 | | Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry | 김현아 |
| 2012 | | Guillain-Barre Syndrome, Antiphospholipid Syndrome and Lupus Nephritis as Initial Manifestation of Systemic Lupus Erythematosus | 김현아, 서창희, 원제환, 정주양, 주인수, 최용우 |
| 2021 | | Health-related Quality of Life Outcomes of Adalimumab for Patients with Rheumatoid Arthritis in Korea | 김현아 |
| 2003 | | Heterogeneity of IgE response to cefteram pivoxil was noted in 2 patients with cefteram-induced occupational asthma. | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2015 | | High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. | 서창희 |
| 2016 | | High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry | 서창희 |
| 2017 | | Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease | 김현아, 서창희, 손성향, 정주양 |
| 2019 | | Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8/A9 in lymph nodes of patients with adult-onset Still's disease | 권지은, 김현아, 한재호 |
| 2003 | | Horner's syndrome as an initial manifestation of Takayasu's arteritis. | 박해심, 서유진, 서창희, 최정희 |
| 2016 | | Hyponatremia in patients with systemic lupus erythematosus | 박세진, 서창희 |
| 2004 | | Hypothermia developed after treatment of high-dose corticosteroid in patient with systemic lupus erythematosus | 김정은, 남동호, 박해심, 서창희, 신유섭, 최정희 |
| 2016 | | Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans | 서창희 |
| 2004 | | Identification of the Major Allergen in the Shrimp (Metapenaeus Joynen): Effects of Heating and Digestive Enzymes | 김현아, 남동호, 서창희, 최정희 |
| 2017 | | Identifying fibromyalgia subgroups using cluster analysis: Relationships with clinical variables | 김현아 |
